These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 24464027)
1. Cyclic peptide analogs of 558-565 epitope of A2 subunit of Factor VIII prolong aPTT. Toward a novel synthesis of anticoagulants. Anastasopoulos C; Sarigiannis Y; Stavropoulos G Amino Acids; 2014 Apr; 46(4):1087-96. PubMed ID: 24464027 [TBL] [Abstract][Full Text] [Related]
2. A novel approach in potential anticoagulants from peptides epitope 558-565 of A2 subunit of factor VIII. Anastasopoulos C; Sarigiannis Y; Stavropoulos G Amino Acids; 2013 Apr; 44(4):1159-65. PubMed ID: 23299973 [TBL] [Abstract][Full Text] [Related]
3. Peptide analogues of 1811-1818 loop of the A3 subunit of the light chain A3-C1-C2 of FVIII of blood coagulation: biological evaluation. Patsialas K; Koutsas C; Makris P; Liakopoulou-Kyriakides M Amino Acids; 2010 Jul; 39(2):481-8. PubMed ID: 20094740 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity. Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922 [TBL] [Abstract][Full Text] [Related]
5. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation. Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442 [TBL] [Abstract][Full Text] [Related]
6. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency. Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A. Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticoagulation studies of "short-armed" fucosylated chondroitin sulfate glycoclusters. Liu H; Zhang X; Wu M; Li Z Carbohydr Res; 2018 Sep; 467():45-51. PubMed ID: 30114596 [TBL] [Abstract][Full Text] [Related]
9. In vitro studies on a novel micelle-forming peptide with anticoagulant activity. Ramesh CV; Jayakumar R; Puvanakrishnan R Int J Pept Protein Res; 1995 Apr; 45(4):386-90. PubMed ID: 7601613 [TBL] [Abstract][Full Text] [Related]
10. Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation. Carle V; Wu Y; Mukherjee R; Kong XD; Rogg C; Laurent Q; Cecere E; Villequey C; Konakalla MS; Maric T; Lamers C; Díaz-Perlas C; Butler K; Goto J; Stegmayr B; Heinis C J Med Chem; 2021 May; 64(10):6802-6813. PubMed ID: 33974422 [TBL] [Abstract][Full Text] [Related]
12. Enzymatic and chemical synthesis of new anticoagulant peptides. Origone A; Bersi G; Illanes A; Sturniolo H; Liggieri C; Guzmán F; Barberis S Biotechnol Prog; 2018 Sep; 34(5):1093-1101. PubMed ID: 29882241 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants. Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity. de Candia M; Fiorella F; Lopopolo G; Carotti A; Romano MR; Lograno MD; Martel S; Carrupt PA; Belviso BD; Caliandro R; Altomare C J Med Chem; 2013 Nov; 56(21):8696-711. PubMed ID: 24102612 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of laminarin sulfates with anticoagulant activity. Alban S; Kraus J; Franz G Arzneimittelforschung; 1992 Aug; 42(8):1005-8. PubMed ID: 1418069 [TBL] [Abstract][Full Text] [Related]
16. Preparation and anticoagulation activity of sodium cellulose sulfate. Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735 [TBL] [Abstract][Full Text] [Related]
17. Monopalmityloxy shikimic acid: enzymatic synthesis and anticoagulation activity evaluation. Tang L; Xiang H; Sun Y; Qiu L; Chen D; Deng C; Chen W Appl Biochem Biotechnol; 2009 Aug; 158(2):408-15. PubMed ID: 19082925 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and structure-activity relationship of a series of fragment analogues of antistasin (ATS) and ghilantens (GLS). Danalev DL; Vezenkov LT; Grigorova B Bioorg Med Chem Lett; 2005 Oct; 15(19):4217-20. PubMed ID: 16084083 [TBL] [Abstract][Full Text] [Related]
19. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy. Bajaj SP; Joist JH Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073 [TBL] [Abstract][Full Text] [Related]